ADGM
Adagio Medical Holdings, Inc.
Key Financials
Revenue
$0
↓ 100.0%
Operating Income
$-21890000
↑ 65.0%
Net Income
$-25084000
↑ 53.3%
Total Assets
$43.3M
↓ 10.7%
EPS (Diluted)
$-1.51
↑ 59.2%
Cash & Equivalents
$17.1M
↓ 16.9%
Total Liabilities
$30.9M
↑ 8.1%
Shareholders' Equity
$12.4M
↓ 37.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/16/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 8-K | 5/21/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 8-K | 4/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADGM |
| Company Name | Adagio Medical Holdings, Inc. |
| CIK | 2006986 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (949) 348-1188 |